Spark Therapeutics: This Looks Bad
December 12, 2017 at 12:31 PM EST
With disappointing data on Spark Therapeutics' hemophilia A gene therapy, a major part of the bull thesis on the stock is gone.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.